Clinical Trials
5 trialsNCT06245122 2026-04-06
A Study of CS23546 in Subjects With Advanced Tumors
Chipscreen Biosciences, Ltd.
Phase 1 Recruiting
NCT07110584 2026-03-05
Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors
ModeX Therapeutics, An OPKO Health Company
Phase 1/2 Recruiting
NCT07205198 2026-01-08
A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.
Shanghai Institute Of Biological Products
Phase 1 Recruiting
NCT07179081 2025-09-17
A Study of AL58805 in Patients With Advanced Tumors
Advenchen Laboratories, LLC
Phase 1 Recruiting
NCT06314087 2025-03-25
Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE)
The University of Hong Kong-Shenzhen Hospital
Phase 2 Recruiting